Literature DB >> 2427583

The human LT system. XII. Purification and functional studies of LT and "TNF-like" LT forms from a continuous human T cell line.

M Kobayashi, J M Plunkett, I K Masunaka, R S Yamamoto, G A Granger.   

Abstract

A clone of the continuous human T cell line HUT-102, termed YM 1.2, can spontaneously release alpha-LT in vitro. However, when stimulated with phorbol myristic acetate, these cells release other LT forms. These LT forms were purified to homogeneity by DEAE chromatography, column isoelectric focusing, and polyacrylamide gel electrophoresis. One LT form, termed LT-2, is a 79,000 m.w. component in aqueous solution and composed of 21,000 m.w. subunits. This form is immunologically related to macrophage-derived TNF and has a lytic capacity in vitro on K-562, Molt-4F, and Raji cells similar to that described for cytotoxins derived from NK effector cells, termed NK-CF. A second LT form, termed LT-3, is a single 69,000 m.w. peptide which could not be reduced into the smaller subunits. This form expresses antigens in common with both alpha-LT and TNF, because both anti-LT and anti-TNF were required to completely neutralize cell lytic activity in vitro. Functional testing revealed that the LT-3 form is lytic on all continuous cells tested in vitro, including NK-resistant target cells. The LT-3 component appears similar by immunologic, biochemical, and functional criteria to the LT form derived from primary human cytolytic T cells in vitro. At the levels tested, none of these LT-TNF forms had measurable effects on primary fibroblasts in vitro.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427583

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Cytostatic activity of dialyzed SDS-page eluates.

Authors:  K K Ericson; T J Yang
Journal:  In Vitro Cell Dev Biol       Date:  1992-01

Review 2.  The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.

Authors:  J W Larrick; S L Kunkel
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

3.  Identity of human B-cell line cytotoxic lymphokine with tumor necrosis factor type beta.

Authors:  H I Yamanaka; A Karpas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  An inhibitor of tumor cell growth from normal horse serum.

Authors:  K K Ericson; T J Yang
Journal:  In Vitro Cell Dev Biol       Date:  1992-01

5.  Immune complex-degradation ability of macrophages in MRL/Mp-lpr/lpr lupus mice and its regulation by cytokines.

Authors:  H Kanno; O Tachiwaki; M Nose; M Kyogoku
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

6.  Lymphotoxin activation by human T-cell leukemia virus type I-infected cell lines: role for NF-kappa B.

Authors:  N L Paul; M J Lenardo; K D Novak; T Sarr; W L Tang; N H Ruddle
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

7.  Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes.

Authors:  M C Cuturi; M Murphy; M P Costa-Giomi; R Weinmann; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

8.  Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.

Authors:  S S Sung; J M Bjorndahl; C Y Wang; H T Kao; S M Fu
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

9.  Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon.

Authors:  C Jupin; S Anderson; C Damais; J E Alouf; M Parant
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.